BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2138173)

  • 1. T cell subpopulations in vitiligo: a chronobiologic study.
    Mozzanica N; Frigerio U; Finzi AF; Cattaneo A; Negri M; Scaglione F; Fraschini F; Foppa S
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):223-30. PubMed ID: 2138173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythm of natural killer cell activity in vitiligo.
    Mozzanica N; Frigerio U; Negri M; Tadini G; Villa ML; Mantovani M; Finzi AF
    J Am Acad Dermatol; 1989 Apr; 20(4):591-6. PubMed ID: 2715406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood lymphocyte imbalance in Koreans with active vitiligo.
    Hann SK; Park YK; Chung KY; Kim HI; Im S; Won JH
    Int J Dermatol; 1993 Apr; 32(4):286-9. PubMed ID: 8486461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell subpopulations and IL-2R in vitiligo.
    Gunduz K; Ozturk G; Terzioglu E; Sebik F
    J Dermatol; 2004 Feb; 31(2):94-7. PubMed ID: 15160861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study.
    Halder RM; Walters CS; Johnson BA; Chakrabarti SG; Kenney JA
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):733-7. PubMed ID: 2940268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo.
    Mozzanica N; Villa ML; Foppa S; Vignati G; Cattaneo A; Diotti R; Finzi AF
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):693-700. PubMed ID: 1316387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
    Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
    J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo.
    Abdallah M; Lotfi R; Othman W; Galal R
    Int J Dermatol; 2014 Aug; 53(8):940-6. PubMed ID: 24527781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects.
    Lévi FA; Canon C; Touitou Y; Reinberg A; Mathé G
    J Clin Invest; 1988 Feb; 81(2):407-13. PubMed ID: 3257498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell profiles in vitiligo.
    Grimes PE; Ghoneum M; Stockton T; Payne C; Kelly AP; Alfred L
    J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):196-201. PubMed ID: 2936773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
    Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
    Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of peripheral blood lymphocytes in patients with vitiligo.
    Sheneef A; Ezz-El DR; Mahmoud TM
    Egypt J Immunol; 2012; 19(1):31-8. PubMed ID: 23888549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
    Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
    Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of T cells in early evolving segmental vitiligo.
    Shin J; Kang HY; Kim KH; Park CJ; Oh SH; Lee SC; Lee S; Choi GS; Hann SK
    Clin Exp Dermatol; 2016 Aug; 41(6):671-4. PubMed ID: 27334675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men.
    Lévi FA; Canon C; Touitou Y; Sulon J; Mechkouri M; Ponsart ED; Touboul JP; Vannetzel JM; Mowzowicz I; Reinberg A
    Clin Exp Immunol; 1988 Feb; 71(2):329-35. PubMed ID: 2964961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease.
    Mazzoccoli G; Balzanelli M; Giuliani A; De Cata A; La Viola M; Carella AM; Bianco G; Tarquini R
    In Vivo; 1999; 13(3):205-9. PubMed ID: 10459492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of circadian rhythmicity of CD3+CD4+ lymphocyte subpopulation in healthy aging.
    Mazzoccoli G; Carughi S; Sperandeo M; Pazienza V; Giuliani F; Greco A
    J Biol Regul Homeost Agents; 2011; 25(3):405-16. PubMed ID: 22023765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑155 inhibits the proliferation of CD8+ T cells via upregulating regulatory T cells in vitiligo.
    Lv M; Li Z; Liu J; Lin F; Zhang Q; Li Z; Wang Y; Wang K; Xu Y
    Mol Med Rep; 2019 Oct; 20(4):3617-3624. PubMed ID: 31485649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes of neuro-endocrine-immune interactions in healthy humans.
    Mazzoccoli G; Correra M; Bianco G; De Cata A; Balzanelli M; Giuliani A; Tarquini R
    J Biol Regul Homeost Agents; 1997; 11(4):143-7. PubMed ID: 9582614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cardiopulmonary bypass on circulating lymphocyte function.
    Nguyen DM; Mulder DS; Shennib H
    Ann Thorac Surg; 1992 Apr; 53(4):611-6. PubMed ID: 1532487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.